Nina Rawal
Direktor/Vorstandsmitglied bei Glionova AB
Ursprung des Netzwerks ersten Grades von Nina Rawal
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Airsonett AB
 Airsonett AB Medical DistributorsDistribution Services Airsonett AB is a holding company that is engaged in the research and development of a non-pharmaceutical treatment for asthma. Its product Airsonett is based on temperature controlled Laminar Airflow technology that creates a radically reduced allergen exposure in the breathing zone for treatment of asthma, allergic rhinitis, and atopic eczema. The company was founded by Jan Tommy Lennart Hedberg, Jan Kristensson, and Dan Kristensson in 2000 and is headquartered in Ängelholm, Sweden.
13
| Holding Company | Medical Distributors | 13 |
Smartfish AS
 Smartfish AS Food RetailRetail Trade Smartfish AS is a holding company that creates drinks for special medical purposes, as well as for people on the go and top athletes to improve their recovery and immune response. It is a research-based company that develops omega 3 based emulsions for brain health, heart health, immune system, and recovery. The firm’s product NutriFriend medical nutrition is sold through pharmacies, medical wholesalers, and directly to hospitals. The company was founded by Janne Sande Mathisen and Henrik Mathisen in 2001 and is headquartered in Oslo, Norway.
10
| Holding Company | Food Retail | 10 |
Trill Impact AB
 Trill Impact AB Investment ManagersFinance Trill Impact AB (Trill Impact) is a private equity firm founded in 2019 by Jan Inge Ståhlberg. The firm is headquartered in Stockholm, Sweden.
7
| Private Company | Investment Managers | 7 |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021.
7
| Public Company | Biotechnology | 7 |
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden.
5
| Private Company | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nina Rawal
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Director of Investments Private Equity Investor Director/Board Member Corporate Officer/Principal Private Equity Investor | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
Avidicare AB
 Avidicare AB Medical DistributorsDistribution Services Avidicare AB operates as a medical device company. It specializes in the management of airborne bacteria and virus pollution at hospitals. The firm provides Opragon, a ventilation system for reduction of airborne bacterial contamination in various hospital environments primarily for infection sensitive surgery. The company offers Opragon for preparation rooms, operating theaters, and hybrid rooms; and air curtains and external air showers. Avidicare was founded in 2010 and is headquartered in Lund, Sweden. | Medical Distributors | Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| MOBERG PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cinclus Pharma AG
 Cinclus Pharma AG BiotechnologyHealth Technology Cinclus Pharma AG is a Swiss Swedish pharmaceutical company founded in 2011. Cinclus Pharma is based in Basel, Switzerland. The private company is focused on bringing relief to people suffering from gastric acid related diseases, particularly gastroesophageal reflux disease (GERD). Cinclus Pharma's clinical stage drug candidate, linaprazan glurate, is a new approach to managing GERD and is showing promising results in acid control and lowering the cmax-value. The company was founded by experts in the field of GERD treatment with extensive experience from Astra and Astra Zeneca. | Biotechnology | Director/Board Member Director/Board Member | |
SEB Venture Capital
 SEB Venture Capital Investment ManagersFinance SEB Venture Capital (SEB Venture Capital) is a venture capital subsidiary of Skandinaviska Enskilda Banken AB founded in 1995. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| Aprea Personal AB | Chairman Chairman | ||
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Director/Board Member Director/Board Member | |
| LIDDS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member | |
EQT Partners, Inc.
 EQT Partners, Inc. Investment ManagersFinance EQT Partners, Inc. is a Private Equity firm, a subsidiary of EQT Partners AB founded in 1994. EQT Partners, Inc. is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
IQVIA Clinical AB
 IQVIA Clinical AB Pharmaceuticals: MajorHealth Technology IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| BIO VITOS PHARMA AB | Medical Specialties | Director/Board Member Director/Board Member | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
EQT Partners AB
 EQT Partners AB Investment ManagersFinance EQT Partners AB (EQT Partners) is a private equity subsidiary of EQT AB founded in 1994 by Yngve Conni Jonsson. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor Private Equity Investor | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Royal Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
| University of Stockholm | College/University | Undergraduate Degree Graduate Degree | |
| MEDIVIR AB | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Kibion AB
 Kibion AB Medical SpecialtiesHealth Technology Kibion AB manufactures and distributes medical test and analytical instruments. It provides solutions for rapid urea breath tests for diagnosing the stomach ulcer bacterium Helicobacter pylori. The firm offers products such as Heliprobe System, Diabact Urea Breath Test, and Kibion Dynamic. The company was founded in 2005 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Forskarpatent i Syd AB
 Forskarpatent i Syd AB Miscellaneous Commercial ServicesCommercial Services Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chairman | |
| Forslid & Co. AB | Director/Board Member | ||
| NATTOPHARMA ASA | Pharmaceuticals: Major | Director/Board Member | |
| Kibacq AB | Director/Board Member | ||
| CREATIVE ANTIBIOTICS SWEDEN AB | Pharmaceuticals: Major | Director/Board Member | |
| Virdings Alle Invest AB | Corporate Officer/Principal | ||
| Rjc Roger Johansson Consulting AB | Corporate Officer/Principal | ||
| Kol Arts & Craft Handelsbolag | Corporate Officer/Principal | ||
Uppsala Innovation Centre AB
 Uppsala Innovation Centre AB Miscellaneous Commercial ServicesCommercial Services Uppsala Innovation Centre AB provides professional training services. The private company is based in Uppsala, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Viogard AB
 Viogard AB Marine ShippingTransportation Viogard AB is a holding company that develops techniques for the production of the active compounds. It conducts research that identified a number of substances which prevents fouling of marine organisms. It produces and sells substances and techniques with anti-fouling properties for protective coating products based on nature’s own defense mechanisms. The company was founded in 2006 by Martin Sjögren, Per Ivar Jösta Claeson and Erika Svangard and is headquartered in Stocksund, Sweden. | Marine Shipping | Director/Board Member | |
| PCG Clinical Services AB | Chief Executive Officer | ||
| Abisco AS | Chairman |
Statistik
International
| Schweden | 43 |
| Norwegen | 5 |
| Vereinigte Staaten | 3 |
| Schweiz | 2 |
| Dänemark | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 6 |
| Commercial Services | 6 |
| Finance | 5 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 300 |
| Corporate Officer/Principal | 82 |
| Chairman | 50 |
| Chief Executive Officer | 39 |
| Independent Dir/Board Member | 36 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Nina Rawal
- Unternehmensverbindungen
